PGR and neoplasm: The specific objectives of this validation study were to not only verify the GP88 cut-off value, but also quantify GP88 performance, and test whether the information in GP88 duplicates or is additive to that found in covariates, such as age, PR expression, tumor size, tumor grade, lymph node status, disease stage and treatments.